Arbutus Biopharma Corp Revenue Breakdown
No Revenue Breakdown for ABUS on this site yet.
- 2025-12-31: Others Not split by product in the filing$14.08M100.00%; Total revenue $14.08M.
- 2024-12-31: Others Not split by product in the filing$6.17M100.00%; Total revenue $6.17M.
- 2023-12-31: Others Not split by product in the filing$18.14M100.00%; Total revenue $18.14M.
- 2022-12-31: Others Not split by product in the filing$39.02M100.00%; Total revenue $39.02M.
Source checked: the stored Revenue Breakdown page for ABUS.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $14.08M 100.00% | $14.08M |
| 2024-12-31 | Not split by product in the filing $6.17M 100.00% | $6.17M |
| 2023-12-31 | Not split by product in the filing $18.14M 100.00% | $18.14M |
| 2022-12-31 | Not split by product in the filing $39.02M 100.00% | $39.02M |
| 2021-12-31 | Not split by product in the filing $10.99M 100.00% | $10.99M |
| 2020-12-31 | Not split by product in the filing $6.91M 100.00% | $6.91M |
| 2019-12-31 | Not split by product in the filing $6.01M 100.00% | $6.01M |
| 2018-12-31 | Not split by product in the filing $5.95M 100.00% | $5.95M |
| 2017-12-31 | Not split by product in the filing $10.70M 100.00% | $10.70M |
| 2016-12-31 | Not split by product in the filing $1.49M 100.00% | $1.49M |
| 2015-12-31 | Not split by product in the filing $23.28M 100.00% | $23.28M |
| 2014-12-31 | Not split by product in the filing $14.95M 100.00% | $14.95M |
| 2013-12-31 | Not split by product in the filing $15.46M 100.00% | $15.46M |
| 2012-12-31 | Not split by product in the filing $14.11M 100.00% | $14.11M |
| 2011-12-31 | Not split by product in the filing $16.81M 100.00% | $16.81M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $1.01M 100.00% | $1.01M |
| 2026-03-31 | Not split by product $179.13M 100.00% | $179.13M |
| 2025-12-31 | Not split by product $1.05M 100.00% | $1.05M |
| 2025-09-30 | Not split by product $529.00K 100.00% | $529.00K |
| 2025-06-30 | Not split by product $10.74M 100.00% | $10.74M |
| 2025-03-31 | Not split by product $1.76M 100.00% | $1.76M |
| 2024-12-31 | Not split by product $1.57M 100.00% | $1.57M |
| 2024-09-30 | Not split by product $1.34M 100.00% | $1.34M |
| 2024-06-30 | Not split by product $1.73M 100.00% | $1.73M |
| 2024-03-31 | Not split by product $1.53M 100.00% | $1.53M |
| 2023-12-31 | Not split by product $2.15M 100.00% | $2.15M |
| 2023-09-30 | Not split by product $4.66M 100.00% | $4.66M |
| 2023-06-30 | Not split by product $4.65M 100.00% | $4.65M |
| 2023-03-31 | Not split by product $6.69M 100.00% | $6.69M |
| 2022-12-31 | Not split by product $6.25M 100.00% | $6.25M |
| 2022-09-30 | Not split by product $5.95M 100.00% | $5.95M |
| 2022-06-30 | Not split by product $14.24M 100.00% | $14.24M |
| 2022-03-31 | Not split by product $12.58M 100.00% | $12.58M |
| 2021-12-31 | Not split by product $3.21M 100.00% | $3.21M |
| 2021-09-30 | Not split by product $3.34M 100.00% | $3.34M |
| 2021-06-30 | Not split by product $2.33M 100.00% | $2.33M |
| 2021-03-31 | Not split by product $2.11M 100.00% | $2.11M |
| 2020-12-31 | Not split by product $2.39M 100.00% | $2.39M |
| 2020-09-30 | Not split by product $1.52M 100.00% | $1.52M |
| 2020-06-30 | Not split by product $1.51M 100.00% | $1.51M |
| 2020-03-31 | Not split by product $1.49M 100.00% | $1.49M |
| 2019-12-31 | Not split by product $1.62M 100.00% | $1.62M |
| 2019-09-30 | Not split by product $3.06M 100.00% | $3.06M |
| 2019-06-30 | Not split by product $653.00K 100.00% | $653.00K |
| 2019-03-31 | Not split by product $679.00K 100.00% | $679.00K |
| 2018-12-31 | Not split by product $1.68M 100.00% | $1.68M |
| 2018-09-30 | Not split by product $1.59M 100.00% | $1.59M |
| 2018-06-30 | Not split by product $1.24M 100.00% | $1.24M |
| 2018-03-31 | Not split by product $1.44M 100.00% | $1.44M |
| 2017-12-31 | Not split by product $2.53M 100.00% | $2.53M |
| 2017-09-30 | Not split by product $6.89M 100.00% | $6.89M |
| 2017-06-30 | Not split by product $1.04M 100.00% | $1.04M |
| 2017-03-31 | Not split by product $235.00K 100.00% | $235.00K |
| 2016-12-31 | Not split by product -$195.00K 100.00% | -$195.00K |
| 2016-09-30 | Not split by product $774.00K 100.00% | $774.00K |
| 2016-06-30 | Not split by product $309.00K 100.00% | $309.00K |
| 2016-03-31 | Not split by product $603.00K 100.00% | $603.00K |
| 2015-12-31 | Not split by product $12.69M 100.00% | $12.69M |
| 2015-09-30 | Not split by product $4.07M 100.00% | $4.07M |
| 2015-06-30 | Not split by product $3.44M 100.00% | $3.44M |
| 2015-03-31 | Not split by product $4.68M 100.00% | $4.68M |
| 2014-12-31 | Not split by product $4.35M 100.00% | $4.35M |
| 2014-09-30 | Not split by product $4.36M 100.00% | $4.36M |
| 2014-06-30 | Not split by product $1.81M 100.00% | $1.81M |
| 2014-03-31 | Not split by product $4.43M 100.00% | $4.43M |
| 2013-12-31 | Not split by product $752.00K 100.00% | $752.00K |
| 2013-09-30 | Not split by product $2.96M 100.00% | $2.96M |
| 2013-06-30 | Not split by product $2.84M 100.00% | $2.84M |
| 2013-03-31 | Not split by product $2.13M 100.00% | $2.13M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |